Nat. Rev. Neurol. doi: /nrneurol

Slides:



Advertisements
Similar presentations
Table 3 Limb-girdle muscular dystrophy standardized data collection form and HPO mapping Thompson, R. & Straub, V. et al. (2016) Limb-girdle muscular dystrophies.
Advertisements

The Changing Face of Cancer in Iowa
Nat. Rev. Neurol. doi:10/1038/nrneurol
Nat. Rev. Neurol. doi: /nrneurol
Prehypertension, Diabetes, and Cardiovascular Disease Risk in a Population-Based Sample by Ying Zhang, Elisa T. Lee, Richard B. Devereux, Jeunliang Yeh,
Figure 3 Life expectancy at birth in all countries included
Figure 1 Perivenous distribution of multiple sclerosis lesions
Figure 2 The US Centers for Disease Control and
Figure 4 Time course of the development of physiological changes
Nat. Rev. Neurol. doi: /nrneurol
with undiagnosed diabetes mellitus by three diagnostic criteria
Figure 1 Hypothetical staging model of sporadic Alzheimer disease (AD)
Nat. Rev. Neurol. doi: /nrneurol
Figure 2 Overview of risk factors for Parkinson disease dementia
Volume 382, Issue 9902, Pages (October 2013)
Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Neurol. doi: /nrneurol
Figure 3 Proportion of patients for whom NEDA
Figure 5 Number of AHSCT procedures for
Figure 1 Diagnostic tiers of Parkinson disease as single disease
Figure 4 Prevalence of HFpEF and HFrEF by age
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Neurol. doi: /nrneurol
Figure 2 Algorithm for immunosuppressive treatment
Nat. Rev. Neurol. doi: /nrneurol
The Changing Face of Cancer in Iowa
Figure 1 Principles of therapeutic ultrasound
Nat. Rev. Neurol. doi: /nrneurol
Volume 382, Issue 9902, Pages (October 2013)
Figure 1 Clinical correlates of neurodegeneration in MS
Nat. Rev. Neurol. doi: /nrneurol
Figure 3 Genetic pleiotropy in ALS
Figure 1 Evolution of multiple sclerosis
Nat. Rev. Cardiol. doi: /nrcardio
Figure 2 Haemorrhagic stroke prevalence and mortality
Figure 1 The trajectory of cognitive ageing
Nat. Rev. Neurol. doi: /nrneurol
DSM-IV delirium prevalence, including the estimated delirium prevalence in the 31 patients that did not undergo delirium assessment following initial screening.
Figure 3 Challenges for big data applications in cardiovascular care
Nat. Rev. Neurol. doi: /nrneurol
Figure 2 Diagnostic scheme for MSA
Figure 3 Stroke-related deaths and DALYs by country development status
Figure 2 Age-specific prevalence of common comorbidities
Figure 6 Combining population-wide and high-risk strategies
Figure 1 Ischaemic stroke prevalence and mortality
Figure 3 Potential interplay between physiological
Nat. Rev. Endocrinol. doi: /nrendo
Nat. Rev. Neurol. doi: /nrneurol
Figure 1 Clinical aspects of LGMD subtypes
Relative risk reduction for incident hypertension associated with weight loss of 6.8 kg: The Framingham Study Cohort Risk reduction (%) Relative risk.
Figure Association of hippocampal subfield volumes to cognition by neopterin level, volumes, and cognition adjusted for age, education, race, sex, and.
Figure 3 Overall survival, according to treatment group
Nat. Rev. Neurol. doi: /nrneurol
Figure 1 Timing of the effects of deep brain stimulation
Figure 5 Interaction between infarction and amyloid deposition
Figure 1 A large number of genes are potentially associated with CIPN
Nat. Rev. Cardiol. doi: /nrcardio
Incidence of choking in London, UK, by gender per 1000 population by age group. Incidence of choking in London, UK, by gender per 1000 population by age.
Pamela E. Scott et al. JACC 2018;71:
Figure 3 Rett syndrome severity and age at diagnosis by mutation type
Nat. Rev. Neurol. doi: /nrneurol
Age-Standardized Rates of Death from Any Cause According to the Estimated GFR among 1,120,295 Ambulatory Adults Alan S.Go et al. N Engl J Med 2004; 351:
Figure 2 A case of early-onset PSD
Flow chart of search strategy
Figure 2 Network connections of the hypothalamus
Adjusted prevalence of CHD, atrial fibrillation, and stroke by sex and ethnic group. Numbers for sex are adjusted for age and clustering within practices.
Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.
Figure Prevalence for MS cumulated over 10 years in the United States per 100,000 population by age and sex 2010 Prevalence for MS cumulated over.
Presentation transcript:

Nat. Rev. Neurol. doi:10.1038/nrneurol.2017.63 Figure 2 Hazard ratio and incidence rate ratio from five studies of dementia incidence Figure 2 | Hazard ratio and incidence rate ratio from five studies of dementia incidence. Reported figures are the ratios of the incidence estimate in new cohorts to that in old cohorts. If incidence estimates remain the same across two cohorts, the ratio is 1.0. If estimates are higher in new cohorts than old cohorts, the ratio is greater than 1.0. Estimates are adjusted as follows: Rotterdam study, IIDP and Bordeaux study adjusted for age; Framingham Heart Study adjusted for age and sex; CFAS adjusted for age, sex, area and deprivation. In the Bordeaux study, clinical diagnosis was made by neuropsychologists and neurologists using criteria from the Diagnostic and Statistical Manual III revised and V, and algorithmic diagnosis was based on cognitive and functional ability tests. CFAS, Cognitive Function and Ageing Study; IIDP, Indianapolis–Ibadan Dementia Project. Wu, Y.-T. et al. (2017) The changing prevalence and incidence of dementia over time — current evidence Nat. Rev. Neurol. doi:10.1038/nrneurol.2017.63